SUBSCRIBE
SUBSCRIBE
News   Drug Development

Novexel Begins Phase I Trial, Gathers In Milestone Payment

October 19, 2005 | 
1 min read

PARIS - Novexel, a specialty pharmaceutical company, initiated a multidose Phase I trial of NXL 103, an orally administered antibiotic for the treatment of bacterial respiratory infections.

Clinical research Phase I Europe
MORE ON THIS TOPIC
Pictured: Sign at J&J Vision offices in Silicon Valley
FDA
J&J Wins Crohn’s Expansion for Tremfya as Stelara Biosimilars Enter US Market
March 21, 2025
 · 
2 min read
 · 
Tristan Manalac
candle flame and sparks home of the fireworks. In the center of the image of the heart"n
Editorial
In Wake of Elevidys Death, Duchenne Patient Community Vows to Push On
March 20, 2025
 · 
3 min read
 · 
Annalee Armstrong
Dorval, Quebec, Canada - September 3, 2021: Novartis Pharmaceuticals Canada Inc. head office building in Dorval, Quebec, Canada. Novartis is a global healthcare company based in Switzerland.
Spinal muscular atrophy
Novartis’ Intrathecal Zolgensma Effective in Older Children
March 19, 2025
 · 
6 min read
 · 
Heather McKenzie
Deviation from the plan, path or norms. Choosing an alternative way, changing the plans and flexibility.
Autoimmune disease
Immunovant Will Drop One Myasthenia Gravis Asset, Continuing to Favor Another
March 19, 2025
 · 
1 min read
 · 
Annalee Armstrong